Đang hiển thị 81 - 89 kết quả của 89 cho tìm kiếm '"Skin Cancers"', thời gian truy vấn: 0.02s Tinh chỉnh kết quả
  1. 81
    Supplementary Table 2 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment

    Supplementary Table 2 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment Bằng Wei Liu (20030)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:
  2. 82
    Supplementary Figure 1 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment

    Supplementary Figure 1 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment Bằng Wei Liu (20030)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:
  3. 83
    Supplementary Figure7 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment

    Supplementary Figure7 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment Bằng Wei Liu (20030)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:
  4. 84
    Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy

    Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1... Bằng Hansol Lee (15054787)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:
  5. 85
    Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy

    Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1... Bằng Hansol Lee (15054787)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:
  6. 86
    Supplementary Table S4 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy

    Supplementary Table S4 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1... Bằng Hansol Lee (15054787)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:
  7. 87
    Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy

    Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1... Bằng Hansol Lee (15054787)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:
  8. 88
    Supplementary Tables S1-7 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases

    Supplementary Tables S1-7 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain... Bằng James S. Wilmott (15008931)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:
  9. 89
    Supplementary Figure S1 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases

    Supplementary Figure S1 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain M... Bằng James S. Wilmott (15008931)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:

Công cụ tìm kiếm: